免费试用——payload抗体助力ADC药物研发

缔码新品|快人一步抢先试用-Anti-Dxd抗体和Anti-SN38抗体
活动时间:2024年2月21日-3月31日
活动对象:终端客户
试用活动产品:DME101025&DME101020

货号名称产品类型
DME101025Anti-Dxd antibody(1A5); Rabbit mAbDimAb monoclonal antibodies
DME101020Anti-SN38 antibody(1G1); Rabbit mAbDimAb monoclonal antibodies

DXd,DX-8951衍生物,是一种新型的、高膜透性拓扑异构酶I抑制剂。DXd抗肿瘤活性强,在血液中的半衰期较短,有利于减少毒副作用的产生;此外,DXd具有强大的细胞膜渗透能力,产生旁观者效应,可杀灭临近的肿瘤细胞,且半衰期缩短。
SN-38,又称为7-ethyl-10-hydroxycamptothecin,是一种半合成喜树碱。SN-38是伊立替康代谢产物,也是其主要的抗肿瘤成分,抑制活性比伊立替康强2到3个数量级。
目前,缔码已开发出多个payload抗体,包括Anti-MMAE抗体、Anti-Dxd抗体和Anti-SN38抗体。这些抗体在众多药物测试中展现了显著功效,在推进ADC开发方面拥有巨大潜力。

Figure 1. Elisa plates were pre-coated with IgG-Dxd (0.2μg/per well). Serial diluted anti-Dxd monoclonal antibody (DME101025) solutions were added, washed, and incubated with secondary antibody before Elisa reading. From above data, the EC50 for anti-Dxd monoclonal antibody binding with IgG-Dxd is 3.447ng/ml.

Figure 2. Elisa plates were pre-coated with IgG-SN38 (0.2μg/per well). Serial diluted anti-SN38 monoclonal antibody (DME101020) solutions were added, washed, and incubated with secondary antibody before Elisa reading. From above data, the EC50 for anti-SN38 monoclonal antibody binding with IgG-SN38 is 11.39ng/ml.

缔码生物现针对Anti-Dxd抗体和Anti-SN38抗体发起试用活动,欢迎有需要的客户扫描以下二维码填写申请表单,参与活动免费领取试用装。

活动说明:
1、活动对象:终端客户(数量有限,先到先得);
2、该活动不与其他优惠同享;
3、本活动最终解释权归缔码生物科技有限公司所有;
4、提交申请表单后会有缔码工作人员与您联系。